Treatment With Sacubitril/valsartan Vs Valsartan Reduces New Loop Diuretic Use In PARAGON-HF

被引：0
|
作者：
Chatur, Safia [1 ]
Vaduganathan, Muthiah [1 ]
Claggett, Brian [1 ]
Vardeny, Orly [2 ]
Jering, Karola [1 ]
Desai, Akshay [1 ]
Pfeffer, Marc [1 ]
McMurray, John
Solomon, Scott [1 ]
机构：
[1] Mass Gen Brigham, Boston, MA USA
[2] Univ Minnesota Med Sch, Minneapolis, MN USA
来源：
JOURNAL OF CARDIAC FAILURE | 2023年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
287
引用
收藏
页码：670 / 670
页数：1
相关论文
共 50 条
  • [41] Response by Jackson et al to Letter Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF"
    Jackson, Alice M.
    Jhund, Pardeep S.
    Solomon, Scott D.
    McMurray, John J. V.
    CIRCULATION, 2020, 142 (01) : E5 - E6
  • [42] Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
    Vaduganathan, Muthiah
    Mentz, Robert J.
    Claggett, Brian L.
    Miao, Zi Michael
    Kulac, Ian J.
    Ward, Jonathan H.
    Hernandez, Adrian F.
    Morrow, David A.
    Starling, Randall C.
    Velazquez, Eric J.
    Williamson, Kristin M.
    Desai, Akshay S.
    Zieroth, Shelley
    Lefkowitz, Martin
    McMurray, John J., V
    Braunwald, Eugene
    Solomon, Scott D.
    EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2982 - 2993
  • [43] Outcomes and effects of sacubitril/valsartan according to NT-proBNP level in patients with heart failure: a patient-level pooled analysis of the PARADIGM-HF and PARAGON-HF trials
    Kondo, T.
    Jhund, P. S.
    Anand, I. S.
    Desai, A. S.
    Lam, C. S. P.
    Maggioni, A. P.
    Martinez, F. A.
    Redfield, M. M.
    Rouleau, J. L.
    Van Veldhuisen, D. J.
    Zannad, F.
    Zile, M. R.
    Packer, M.
    Solomon, S. D.
    Mcmurray, J. J., V
    EUROPEAN HEART JOURNAL, 2024, 45
  • [44] Efficacy and safety of sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction according to background MRA therapy: a pooled analysis of PARAGLIDE-HF and PARAGON-HF
    Inciardi, Riccardo Maria
    Mentz, R. J.
    Claggett, B.
    Ward, J. H.
    Hernandez, A. F.
    Morrow, D. A.
    Starling, R. C.
    Velazquez, E. J.
    Desay, A. S.
    Zieroth, S.
    Lefkowitz, M.
    Mcmurray, J. J. V.
    Braunwald, E.
    Solomon, S. D.
    Vaduganathan, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 67 - 67
  • [45] EFFECTS OF SACUBITRIL/VALSARTAN OR VALSARTAN IN DE NOVO VS. CHRONIC HFPEF AND HFMREF: THE PARAGLIDE-HF TRIAL
    Murray, Evan
    Cyr, Derek D.
    Morrow, David A.
    Starling, Randall C.
    Zieroth, Shelley R.
    Hernandez, Adrian F.
    Williamson, Kristin
    Lepage, Serge
    Fudim, Marat
    Desai, Akshay S.
    Ward, Jonathan
    Solomon, Scott D.
    Mentz, Robert John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 4607 - 4607
  • [46] Cardiovascular-kidney-metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF
    Lassen, Mats C. H.
    Ostrominski, John W.
    Claggett, Brian L.
    Packer, Milton
    Zile, Michael
    Desai, Akshay S.
    Shah, Amil M.
    Cikes, Maja
    Merkely, Bela
    Gori, Mauro
    Wang, Xiaowen
    Hegde, Sheila M.
    Pfeffer, Marc A.
    Lefkowitz, Martin
    McMurray, John J. V.
    Solomon, Scott D.
    Vaduganathan, Muthiah
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (08) : 1762 - 1774
  • [47] Reduced thiazide diuretic use in hfref patients taking sacubitril/valsartan (arni)
    Mannion, T.
    Connor, L. O.
    Mcadam, B.
    James, S.
    Haire, J. Kelly O.
    Gara, G. O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 273 - 273
  • [48] Letter by Tuncez and Gurses Regarding Article, "Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF"
    Tuncez, Abdullah
    Gurses, Kadri Murat
    CIRCULATION, 2025, 151 (06) : e37 - e37
  • [49] SACUBITRIL/VALSARTAN VS ENALAPRIL USE IN THE OUTPATIENT FACILITIES SETTING IN SPAIN
    Parrondo Garcia, F. J.
    Garcia-Quintana, A.
    VALUE IN HEALTH, 2023, 26 (12) : S141 - S141
  • [50] Response by Shen et al to Letter Regarding Article, "Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF"
    Shen, Li
    Jhund, Pardeep S.
    Mcmurray, John J. V.
    CIRCULATION, 2025, 151 (06) : e38 - e38
12345